TDCS and Tele-rehabilitation Exercise in Fibromyalgia

Launched by UNIVERSITY OF VALLADOLID · Sep 24, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a treatment called anodal transcranial direct current stimulation (tDCS) works when combined with an exercise program delivered remotely for people with fibromyalgia. Fibromyalgia is a condition that causes widespread pain, fatigue, and other symptoms. The trial will have three groups: one group will receive tDCS over a specific part of the brain along with the exercise program, another group will receive tDCS over a different brain area with the same exercise program, and the last group will receive a placebo treatment (a fake version of tDCS) with the exercise. The study will last for 12 weeks and will track things like pain levels, quality of life, and how well participants can exercise.

To participate, individuals should be between 30 and 70 years old, have a medical diagnosis of fibromyalgia, and have been stable on their medications for at least 12 weeks. Participants should also be comfortable using technology like smartphones or computers, have internet access, and be able to understand and communicate in Spanish. Throughout the study, participants can expect to engage in a structured exercise program that includes both aerobic and strength training activities, all guided remotely. The trial aims to help understand the effectiveness of these treatments and any side effects that may occur.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 30 and 70 years.
• • Medical diagnosis of fibromyalgia.Compliance with the latest diagnostic criteria from the American College of Rheumatology.
• • Stable medication for at least 12 weeks prior to the start of the study.
• • Ability to use communication technologies, such as smartphones and computers.
• • Capacity to participate in an aerobic exercise program.
• • Access to the internet.
• • Proficiency in oral and written Spanish.
• • Signed informed consent
• Exclusion Criteria:
• • Severe psychiatric disorders.
• • Uncontrolled cardiovascular, respiratory, metabolic, neurological, rheumatic, or hepatic diseases.
• • Concurrent chronic inflammatory or autoimmune disease.
• • Contraindications to physical activity.
• • Metal implants in the head.
• • History of cancer, brain tumor, epileptic episodes, stroke, severe head trauma, or brain surgery.
• • Pregnancy or lactation.
• • Use of carbamazepine in the past 6 months.
• • Changes in medication during the study.
• • Participation in other non-pharmacological conservative therapies (e.g., hydrotherapy, electrotherapy, manual therapy, exercise, dry needling) during the study.